Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year

Kidney International

Volumn 55, Issue 2, 1999, Pages 674-685

  Benigni, Ariela ^a,b   Bruzzi, Isabella ^a   Mister, Marilena ^a   Azzollini, Nadia ^a   Gaspari, Flavio ^a   Perico, Norberto ^a   Gotti, Eliana ^a   Bertani, Tullio ^a   Remuzzi, Giuseppe ^a  

^a OSPEDALI RIUNITI   (Italy)

^b MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

Endothelin 1; Interstitial fibrosis; MCP 1; Nephrotoxicity; RANTES; Renal transplantation; Vasoconstriction

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; ENDOTHELIN 1; MONOCYTE CHEMOTACTIC PROTEIN; STEROID;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY BLOOD FLOW; KIDNEY CLEARANCE; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PERFUSION; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; PRIORITY JOURNAL; SURVIVAL RATE; VASOCONSTRICTION;

EID: 0032961456     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00288.x     Document Type: Article

References (47)

1. 1. CANADIAN MULTICENTRE TRANSPLANT STUDY GROUP: A randomized clinical trial of cyclosporine in cadaveric renal transplants. N Engl J Med 309:809-814, 1983
2. 2. GORDON RD, SHAW BW, IWATSUKI S: Indications for liver transplantation in cyclosporine era. Surg Clin North Am 66:541-546, 1986
3. 3. OYER PE, STINSON EB, JAMIESON SW: Cyclosporine in cardiac transplantation: A 2 1/2 year follow-up. Transplant Proc 15:2546-2552, 1983
4. 4. DIEPERINK H, PERICO N, NIELSEN FT, REMUZZI G: Cyclosporine/tacrolimus (FK-506), in Clinical Nephrotoxins: Renal Injury from Drugs and Chemicals, edited by DE BROE ME, PORTER GA, BENNETT WM, VERPOOTEN GA, Dordrecht, Kluwer Academic, 1998, pp 275-300
5. 5. REMUZZI G, PERICO N: Cyclosporine-induced renal dysfunction in experimental animals and humans. Kidney Int 48(Suppl 52):S70-S74, 1995
6. 6. BENNETT WM, DE MATTOS A, MEYER MM, ANDOH T, BARRY JM: Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy. Kidney Int 50:1089-1100, 1996
7. 7. PERICO N, REMUZZI G: Cyclosporine-induced renal dysfunction in experimental animals and humans. Transplant Rev 5:63-80, 1991
8. 8. MYERS B: Cyclosporine nephrotoxicity. Kidney Int 30:964-974, 1986
9. 9. KAHAN BD: Cyclosporine. N Engl J Med 321:1725-1738, 1989
10. 10. MYERS B, NEWTON L: Cyclosporine-induced chronic renal nephropathy: An obliterative microvascular renal injury. J Am Soc Nephrol 2:S45-S52, 1991
11. 11. MIHATSCH MJ, RYFFEL B, GUDAT F: The differential diagnosis between rejection and cyclosporine toxicity. Kidney Int 48(Suppl 52):S63-S69, 1995
12. 12. MIHATSCH MJ, THIEL G, RYFFEL B: Histopathology of cyclosporine nephrotoxicity. Transplant Proc 20(Suppl 3):759-771, 1988
13. 13. MYERS BD, NEWTON L, BOSHKOS C, MACOVIAK J, FRIST W, DERBY G, PELROTH M, SIBLEY R: Chronic injury of human renal microvessels with low-dose cyclosporine therapy. Transplantation 46:694-703, 1988
14. 14. ANDOTH TF, BENNETT WM: Chronic cyclosporine nephrotoxicity. Curr Opin Nephrol Hypertens 7:265-270, 1998
15. 15. CONGER JD, KIM GE, ROBINETTE JB: Effects of Ang II, ETA, and TxA2 receptor antagonists on cyclosporin A renal vasoconstriction. Am J Physiol 267:F443-F449, 1994
16. 16. BOBADILLA NA, TAPIA E, FRANCO M, LOPEZ P, MENDOZA S, GARCIA-TORRES R, ALVARADO JA, HERRERA-ACOSTA J: Role of nitric oxide in renal hemodynamic abnormalities of cyclosporin nephrotoxicity. Kidney Int 46:773-779, 1994
17. 17. ROSSI NF, CHURCHILL PC, MCDONALD FD, ELLIS VR: Mechanism of cyclosporin A-induced renal vasoconstriction in the rat. J Pharmacol Exp Ther 250:896-901, 1989
18. 18. ROSEN S, GREENFELD Z, BREZIS M: Chronic cyclosporine-induced nephropathy in the rat: A medullary ray and inner stripe injury. Transplantation 49:445-452, 1990
19. 19. ELZINGA LW, ROSEN S, BENNETT WM: Dissociation of glomerular filtration rate from tubulointerstitial fibrosis in experimental chronic cyclosporine nephropathy: Role of sodium intake. J Am Soc Nephrol 4:214-221, 1993
20. 20. GASPARI F, PERICO N, RUGGENENTI P, MOSCONI L, AMUCHASTEGUI CS, GUERINI E, DAINA E, REMUZZI G: Plasma clearance of non-radioactive iohexol as a measure of glomerular filtration rate. J Am Soc Nephrol 6:257-263, 1995
21. 21. PERICO N, RUGGENENTI P, GASPARI F, MOSCONI L, BENIGNI A, AMUCHASTEGUI CS, GASPARINI F, REMUZZI G: Daily renal hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 54:56-60, 1992
22. 22. SOLEZ K, AXELSEN RA, BENEDIKTSSON H, BURDICK JF, COHEN AH, COLVIN RB, CROKER BP, DROZ D, DUNNILL MS, HALLORAN PF, HAYRY P, JENNETTE JC, KEOWN PA, MARCUSSEN N, MIHATSCH MJ, MOROZUMI K, MYERS BD, NAST CC, OLSEN S, ROSEN S, SACHS DH, SALOMON DR, SANFILIPPO F, VERANI R, VON WILLEBRAND E, YAMAGUCHI Y: International standardization of criteria for the histologic diagnosis of renal allograft rejection: The Banff working classification of kidney transplant pathology. Kidney Int 44:411-422, 1993
23. 23. MIHATSCH MJ, RYFFEL B, GUDAT F, THIEL G: Cyclosporine nephrotoxicity, in Renal Pathology: With Clinical and Functional Correlations, edited by TISHER CC, BRENNER BM, Philadelphia, JB Lippincott Company, 1994, pp 1641-1681
24. 24. CROCKER BP, RAMOS EL: Pathology of the renal allograft, in Renal Pathology: With Clinical and Functional Correlations, edited by TISHER CC, BRENNER BM, Philadelphia, JB Lippincott Company, 1994, pp 1590-1640
25. 25. BRUZZI I, CORNA D, ZOJA C, ORISIO S, SCHIFFRIN EL, CAVALLOTTI D, REMUZZI G, BENIGNI A: Time course and localization of endothelin-1 gene expression in a model of renal disease progression. Am J Pathol 151:1241-1247, 1997
26. 26. BROCHNER-MORTENSEN J: A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30:271-274, 1972
27. 27. SMITH HW, FINKELSTEIN N, ALIMINOSA L, CRAWFORD B: The renal clearance of substituted hippuric acid derivatives and other aromatic acid in dog and man. J Clin Invest 24:388-404, 1945
28. 28. GASPARI F, ANEDDA MF, SIGNORINI O, REMUZZI G, PERICO N: Prediction of cyclosporine area under the curve using a three-point sampling strategy after Neoral administration. J Am Soc Nephrol 8:647-652, 1997
29. 29. PEETERS J, ROELS L, VANRENTERGHEM Y, LEUVEN COLLABORATIVE GROUP FOR TRANSPLANTATION: Chronic renal allograft failure: Clinical overview. Kidney Int 48(Suppl 52):S97-S101, 1995
30. 30. FEUTREN G, MIHATSCH MJ, INTERNATIONAL KIDNEY BIOPSY REGISTRY OF CYCLOSPORINE IN AUTOIMMUNE DISEASES: Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. N Engl J Med 326:1654-1660, 1992
31. 31. BERTANI T, FERRAZZI P, SCHIEPPATI A, RUGGENENTI P, GAMBA A, PARENZAN L, MECCA G, PERICO N, IMBERTI O, REMUZZI A, REMUZZI G: Nature and extent of glomerular injury by cyclosporine in heart transplant patients. Kidney Int 40:243-250, 1991
32. 32. LAFAYETTE RA, MAYER G, MEYER TW: The effects of blood pressure reduction on cyclosporine nephrotoxicity in the rat. J Am Soc Nephrol 3:1892-1899, 1993
33. 33. SHIHAB FS, BENNETT WM, TANNER AM, ANDOH TF: Angiotensin II blockade decreases TGF-beta-1 and matrix proteins in cyclosporine nephropathy. Kidney Int 52:660-673, 1997
34. 34. ONG ACM, JOWETT TP, FIRTH JD, BURTON S, KITAMURA M, FINE LG: A new paracrine loop implicated in human tubulo-interstitial fibrosis: Tubular-derived endothelins modulate renal interstitial fibroblast function. (abstract) J Am Soc Nephrol 4:473, 1993
35. 35. CHEN XM, YU LF, ZENG Q: Production of endothelin (ET-1) in kidney tubular cell (LLC-PK1) induced by extracellular matrix (ECM). (abstract) International Congress of Nephrology, Madrid (Spain) July 2-6, 1995, pp 299
36. 36. EDDY AA: Expression of genes that promote renal interstitial fibrosis in rats with proteinuria. Kidney Int 49(Suppl 54):S49-S54, 1996
37. 37. REMUZZI G, BERTANI T: Pathophysiology of progressive nephropathies. N Engl J Med (in press)
38. 38. BENIGNI A, MORIGI M, PERICO N, ZOJA C, AMUCHASTEGUI CS, PICCINELLI A, DONADELLI R, REMUZZI G: The acute effect of FK506 and cyclosporine on endothelial cell function and renal vascular resistance. Transplantation 54:775-780, 1992
39. 39. BUNCHMAN TE, BROOKSHIRE CA: Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest 88:310-314, 1991
40. 40. NAKAHAMA H: Stimulatory effect of cyclosporine A on endothelin secretion by a cultured renal epithelial cell line, LLC-PK1 cells. Eur J Pharmacol 180:191-192, 1990
41. 41. BENIGNI A, PERICO N, LADNY JR, IMBERTI O, BELLIZZI L, REMUZZI G: Increased urinary excretion of endothelin-1 and its precursor big endothelin-1 in rats chronically treated with cyclosporine. Transplantation 52:175-177, 1991
42. 42. VON WILLEBRAND E, HAYRY P, AHONEN J: Differential diagnosis of cyclosporin (CyA) nephrotoxicity versus rejection by fine needle aspiration biopsy (FNAB). (abstract) Kidney Int 24:418, 1983
43. 43. VON WILLEBRAND E, HAYRY P: Cyclosporine A deposits in renal allografts. Lancet 2:189-192, 1983
44. 44. GARCIA DEL MORAL R, O'VALLE F, ANDUJAR M, AGUILAR M, LUCENA MA, LOPEZ-HIDALGO J, RAMIREZ C, MEDINA-CANO MT, AGUILAR D, GOMEZ-MORALES M: Relationship between p-glucoprotein expression and cyclosporin A in kidney: An immunohistological and cellular culture study. Am J Pathol 146:398-408, 1995
45. 45. ZOJA C, MORIGI M, FIGLIUZZI M, BRUZZI I, OLDROYD S, BENIGNI A, RONCO P, REMUZZI G: Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins. Am J Kidney Dis 26:934-941, 1995
46. 46. ZOJA C, DONADELLI R, COLLEONI S, REMUZZI G: Protein overload stimulates RANTES production by proximal tubular cells depending on NF-κB activation. Kidney Int (in press)
47. 47. WANG Y, CHEN J, CHEN L, TAY Y-C, RANGAN GK, HARRIS DCH: Induction of monocytes chemoattractant protein-1 in proximal tubule cells by urinary protein. J Am Soc Nephrol 8:1537-1545, 1997